欢迎来到第壹文秘! | 帮助中心 分享价值,成长自我!
第壹文秘
全部分类
  • 幼儿/小学教育>
  • 中学教育>
  • 高等教育>
  • 研究生考试>
  • 外语学习>
  • 资格/认证考试>
  • 论文>
  • IT计算机>
  • 法律/法学>
  • 建筑/环境>
  • 通信/电子>
  • 医学/心理学>
  • ImageVerifierCode 换一换
    首页 第壹文秘 > 资源分类 > PPT文档下载
    分享到微信 分享到微博 分享到QQ空间

    软组织肿瘤.ppt

    • 资源ID:651185       资源大小:3.14MB        全文页数:76页
    • 资源格式: PPT        下载积分:10金币
    快捷下载 游客一键下载
    账号登录下载
    三方登录下载: 微信开放平台登录 QQ登录
    下载资源需要10金币
    邮箱/手机:
    温馨提示:
    快捷下载时,如果您不填写信息,系统将为您自动创建临时账号,适用于临时下载。
    如果您填写信息,用户名和密码都是您填写的【邮箱或者手机号】(系统自动生成),方便查询和重复下载。
    如填写123,账号就是123,密码也是123。
    支付方式: 支付宝    微信支付   
    验证码:   换一换

    加入VIP,免费下载
     
    账号:
    密码:
    验证码:   换一换
      忘记密码?
        
    友情提示
    2、PDF文件下载后,可能会被浏览器默认打开,此种情况可以点击浏览器菜单,保存网页到桌面,就可以正常下载了。
    3、本站不支持迅雷下载,请使用电脑自带的IE浏览器,或者360浏览器、谷歌浏览器下载即可。
    4、本站资源下载后的文档和图纸-无水印,预览文档经过压缩,下载后原文更清晰。
    5、试题试卷类文档,如果标题没有明确说明有答案则都视为没有答案,请知晓。

    软组织肿瘤.ppt

    成人软组织肉瘤化疗成人软组织肉瘤化疗Contents lOverviewlDrugslTreatmentneoadjuvant chemotherapyadjuvant chemotherapyAdvanced or metastatic diseases chmeotherapytargeted therapyContents lOverviewlDrugslTreatmentneoadjuvant chemotherapyadjuvant chemotherapytargeted therapylSarcomas constitute a heterogeneous group of rare solid tumors oflmesenchymal cell origin with distinct clinical and pathological featuresl成人软组织肉瘤(成人软组织肉瘤(Soft tissue sarcomas,STSs),包),包括一组发病相对较少,组织学多样的恶性肿瘤。括一组发病相对较少,组织学多样的恶性肿瘤。l起源中胚层和外胚层。起源中胚层和外胚层。l占成人恶性肿瘤的占成人恶性肿瘤的1%和儿童恶性肿瘤的和儿童恶性肿瘤的5%。l尚无特别有效的治疗方法,需多学科联合。尚无特别有效的治疗方法,需多学科联合。Categories lSarcomas of soft tissues(including fat,muscle,nerve and nerve sheath,blood vessels,and other connective tissues)l Sarcomas of bone.The anatomic site of the primary diseaselExtremities(60%)l the trunk(19%)l retroperitoneum(15%)lhead and neck(9%)Risk factorslAge.Soft tissue sarcomas can occur at any age,but overall are more common in older adults.The average age at diagnosis is 57 years.Certain types of sarcomas are more common in children,however.lChemical exposure.Being exposed to certain chemicals,such as vinyl chloride and dioxin,can increase the risk of soft tissue sarcomas.lRadiation exposure.Previous radiation treatment for other cancers can increase the risk of soft tissue sarcomas.Signs and symptomsla new lump or a lump that is growing anywhere in the body may or may not cause pain may include abdominal swelling or a lump in the abdomenlnausea lvomiting lheartburn labdominal pain lblood in vomit or stoolAdult soft tissue sarcoma diagnosedlIncisional biopsy:The removal of part of a lump or a sample of tissue.lCore biopsy:The removal of tissue using a wide needle.lExcisional biopsy:The removal of an entire lump or area of tissue that doesnt look normal.core needle biopsyPathology and staginglthe type of soft tissue sarcoma lthe stage of the cancer(how far the cancer has progressed)lthe grade of the tumour(how abnormal the cancer cells look and behave)lPleomorphic sarcoma also known as malignant fibrous histiocytoma(MFH)l GISTslLiposarcomal leiomyosarcomal synovial sarcomal malignant peripheral nerve sheath tumorsIncidence of Soft Tissue Sarcoma Subtypes(1978-2001)Histologic Subtype%平滑肌肉瘤23.9恶性纤维组织细胞瘤17.1脂肪肉瘤11.5皮肤纤维肉瘤10.5横纹肌肉瘤4.6血管肉瘤4.1Sites of MetastasisGadd M,et al,Ann Surg,1993Contents lOverviewlDrugslTreatmentneoadjuvant chemotherapyadjuvant chemotherapytargeted therapyChemotherapy lSingle Agents DoxorubicinIfosfamideDacarbazineGemcitabinePaclitaxelDocetaxelChemotherapyPemetrexedTemozlomideIrinotecanTopotecanPelyated liposmal doxorubicinTrabectedinDoxorubicinlThe single agent response rates(RR)are in the range of 20 to 30%lsurvival in the range of 7.7-12 months lThe best response rates are seen with dosages in the range of 75 mg/m 2 to 90 mg/m 2 DoxorubicinlEpirubicin is a less cardiotoxic analog of doxorubicin,which failed to demonstrate any benefit as compared to doxorubicinlliposomal doxorubicin can be used in patients where doxorubicin is contraindicated,but the response rates of this drug as a single agent are lower than the conventional doxorubicin.Ifosfamidela dose-response relationship and higher doses can be used as it lacks cardiotoxicity lmonotherapy with an identical dose(9 g/m 2),given over three days,by either continuous infusion or three-hour infusions daily Dacarbazinelin combination with doxorubicin and ifosfamide(MAID)lgiven as a short infusion of 1.2 g/m 2 over 20 minutes with the availability of effective antiemetics.TemozolamidelTemozolamide,the oral equivalent of dacarbazine,appears to have the same activity against leiomyosarcoma as well.Trabectedin(Ecteinascidin-743,ET743,Yondelis)lThis tetrahydroisoquinsoline molecule was derived originally from a tunicate,or sea squirt,Ecteinascidia turbinate(found in the Carribbean and Mediterranean waters)lA pooled analysis of 183 patients from the three single arm phase II studiesl1.5 mg/m 2 administered as a 24-hour infusion once every three weekslIn this analysis though the ORR was only 7.7%,the rate of tumor control(i.e.,ORR plus minor responses plus disease stabilization)was 51%.Contents lOverviewlDrugslTreatmentneoadjuvant chemotherapyadjuvant chemotherapyAdvanced or metastatic diseases chmeotherapytargeted therapyTreatmentlsurgery Surgery is the most common treatment for many soft tissue sarcomas.Depending on the size and location of the sarcoma,all or part of the tumour may be removed.If the whole tumour is removed,a wide margin of healthy tissue around it is also removed.In many cases,limb-sparing surgery can be done for a soft tissue sarcoma that occurs in an arm or leg and amputation can be avoided.However,in some cases,soft tissue sarcoma in a limb may require the limb to be amputated.lradiation therapy Radiation therapy may be used before or after surgery or,less commonly,instead of surgery.lchemotherapy If the soft tissue sarcoma has spread to other parts of the body,chemotherapy may be used to control the cancer and relieve symptoms.Chemothera

    注意事项

    本文(软组织肿瘤.ppt)为本站会员(p**)主动上传,第壹文秘仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对上载内容本身不做任何修改或编辑。 若此文所含内容侵犯了您的版权或隐私,请立即通知第壹文秘(点击联系客服),我们立即给予删除!

    温馨提示:如果因为网速或其他原因下载失败请重新下载,重复下载不扣分。




    关于我们 - 网站声明 - 网站地图 - 资源地图 - 友情链接 - 网站客服 - 联系我们

    copyright@ 2008-2023 1wenmi网站版权所有

    经营许可证编号:宁ICP备2022001189号-1

    本站为文档C2C交易模式,即用户上传的文档直接被用户下载,本站只是中间服务平台,本站所有文档下载所得的收益归上传人(含作者)所有。第壹文秘仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对上载内容本身不做任何修改或编辑。若文档所含内容侵犯了您的版权或隐私,请立即通知第壹文秘网,我们立即给予删除!

    收起
    展开